Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

World Marrow Donor Association: a progress report

J M Goldman1, S Cleaver, P Warren

  • 1Haematology Department, Royal Postgraduate Medical School, London, UK.

Bone Marrow Transplantation
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.

Blood·1996
Same author

Overexpression of EVI-1 in blast crisis of chronic myeloid leukemia.

Leukemia·1996
Same author

Organ-specific contribution to circulating C7 levels by the bone marrow and liver in humans.

European journal of immunology·1996
Same author

Phenotype and progeny of primitive adherent human hematopoietic progenitors.

Leukemia·1996
Same author

Expression of the LH2 gene in chronic myeloid leukaemia cells.

Leukemia·1996
Same author

Reverse transcription/polymerase chain reaction (RT/PCR) amplification of very small numbers of transcripts: the risk in misinterpreting negative results.

Leukemia·1996
Same journal

CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.

Bone marrow transplantation·2026
Same journal

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Bone marrow transplantation·2026
Same journal

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same journal

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
Same journal

Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

Bone marrow transplantation·2026
Same journal

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
See all related articles

The World Marrow Donor Association (WMDA) was established in 1988 to create global guidelines for volunteer bone marrow donors in international transplants. They standardized practices for bone marrow transplantation through regular meetings and a 1992 report.

Area of Science:

  • Hematology
  • Transplantation Medicine
  • International Health

Background:

  • The World Marrow Donor Association (WMDA) was founded in 1988.
  • The WMDA aimed to establish international guidelines for volunteer bone marrow donors.
  • Global collaboration in bone marrow transplantation was identified as a need.

Purpose of the Study:

  • To establish guidelines for the use of volunteer bone marrow donors in international transplants.
  • To promote standardized practices in bone marrow transplantation worldwide.
  • To facilitate collaboration between international bone marrow donor registries.

Main Methods:

  • The WMDA was founded in 1988.
  • Members have met approximately twice yearly since its inception.

Related Experiment Videos

  • A Special Report was published in 1992 detailing recommendations and requirements.
  • Main Results:

    • Established guidelines for international bone marrow donor use.
    • Promoted standardized practices for bone marrow transplants globally.
    • Facilitated international cooperation in marrow donation.

    Conclusions:

    • The WMDA successfully laid the groundwork for international bone marrow donor collaboration.
    • Standardized practices were recommended to improve global bone marrow transplant outcomes.
    • The association's efforts aimed to increase the availability of suitable donors for patients worldwide.